I would appreciate any input from those using Becton-Dickinson monoclonal antibodies CD158, 161, and KIR. Are you routinely successful using these markers? We are especially interested in success with KIR. Chris
This archive was generated by hypermail 2b29 : Wed Apr 03 2002 - 11:53:04 EST